Publications du service de microbiologie-infectiologie du CHUM

Description
Veille informationnelle

Sujets couverts
Publications du service de microbiologie-infectiologie du CHUM

Sources
Scopus

Fréquence
Trimestrielle

Bibliothécaire responsable
Daniela Ziegler
daniela.ziegler.chum@ssss.gouv.qc.ca

S’abonner

Catégorie:

Description

2025

Janvier – Mars

  1. Mourot A, Chalut M, Grandjean-Lapierre S, Younan R, Bourré-Tessier J. Treatment of idiopathic granulomatous mastitis: a retrospective case series. Rheumatology International. 2025;45(1):20. https://doi.org/10.1007/s00296-024-05773-4

  2. Bitterman R, Soualhine H, Akochy P-M, Poirier C, Ferraro P, Kabbani D, et al. Mycobacterium abscessus Complex Infections Among Lung Transplant Recipients: A Multicenter Retrospective Cohort Study in Canada. Transplant Infectious Disease. 2025;n/a(n/a):e70003. https://onlinelibrary.wiley.com/doi/abs/10.1111/tid.70003

  3. Chawla S, Kaida A, Brouillette M-J, Kleiner B, Dubuc D, Skerritt L, et al. Impact of mental health service use on the HIV care cascade among women. HIV Medicine. 2025;n/a(n/a). https://onlinelibrary.wiley.com/doi/abs/10.1111/hiv.70008

  4. Spinner CD, Bell S, Einsele H, Tremblay C, Goldman M, Chagla Z, et al. Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals. Advances in Therapy. 2025;42(2):666-719. https://doi.org/10.1007/s12325-024-03043-0

  5. El Sheikh MZ, Young J, Panagiotoglou D, Cooper C, Cox J, Martel-Laferrière V, et al. Progress toward hepatitis C virus elimination among people living with HIV–hepatitis C virus coinfection in Canada. Canadian Liver Journal. 2025;8(1):49-62. https://utppublishing.com/doi/abs/10.3138/canlivj-2024-0042

  6. Olawoye IB, Waglechner N, McIntosh F, Akochy P-M, Cloutier N, Grandjean Lapierre S, et al. Genomic Epidemiology of Mycobacterium abscessus on the Island of Montréal Is Not Suggestive of Health Care-Associated Person-to-Person Transmission. The Journal of Infectious Diseases. 2024;231(2):e396-e406. https://doi.org/10.1093/infdis/jiae407

  7. Nayyerabadi M, Fourcade L, Joshi SA, Chandrasekaran P, Chakravarti A, Massé C, et al. Corrigendum to “Vaccination after developing long COVID: Impact on clinical presentation, viral persistence and immune responses” [International Journal of Infectious Diseases, volume 136 (2023), 136–145, doi:10.1016/j.ijid.2023.09.006]. International Journal of Infectious Diseases. 2025;153:107842. https://www.sciencedirect.com/science/article/pii/S1201971225000657

  8. Chandrasekaran P, Krausz M, Han Y, Mitsuiki N, Gabrysch A, Nöltner C, et al. Correction: The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency. 2025;13(1):74. https://doi.org/10.1186/s40168-025-02069-y

  9. Pickering H, Schaenman J, Phan HV, Maguire C, Tsitsiklis A, Rouphael N, et al. Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients. Nature Communications. 2025;16(1):586. https://doi.org/10.1038/s41467-025-55823-z

  10. Chandrasekaran P, Krausz M, Han Y, Mitsuiki N, Gabrysch A, Nöltner C, et al. The intestinal microbiome and metabolome discern disease severity in cytotoxic T-lymphocyte-associated protein 4 deficiency. Microbiome. 2025;13(1):51. https://doi.org/10.1186/s40168-025-02028-7

  11. Bédard K, Boisvert I, Rochette M, Racine E, Martel-Laferrière V. Exploring the value and acceptability of a patient navigator program for people who inject drugs and are hospitalized for bacterial infections: patients’, community organization and healthcare workers’ perspectives. BMC Infectious Diseases. 2025;25(1):221. https://doi.org/10.1186/s12879-025-10617-y

2024

  1. Prévost R, Roy-St-pierre É, Idir K, Khodamoradi A, Provost F, Martel D, et al. Hepatitis C screening in community pharmacies—A feasibility and knowledge transfer study: PHARMA-C. 2024;9(3):161-72. https://utppublishing.com/doi/epub/10.3138/jammi-2024-0010

  2. Kassam P, El-Zein M, Tota JE, Tellier PP, Coutlee F, de Pokomandy A, Franco EL. HPV vaccination and anal HPV infection in gay, bisexual, and other men who have sex with men. 2024;45:126644. https://www.ncbi.nlm.nih.gov/pubmed/39708517

  3. Spinner CD, Bell S, Einsele H, Tremblay C, Goldman M, Chagla Z, et al. Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals. Adv Ther. 2024. https://www.ncbi.nlm.nih.gov/pubmed/39680311

  4. Moreira Gabriel E, Dias J, Caballero RE, Salinas TW, Nayrac M, Filali-Mouhim A, et al. Novel Immunological Markers of Intestinal Impairment Indicative of HIV-1 Status and/or Subclinical Atherosclerosis. bioRxiv. 2024. https://www.ncbi.nlm.nih.gov/pubmed/39651272

  5. Tan JK, Servellita V, Stryke D, Kelly E, Streithorst J, Sumimoto N, et al. Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery. Nat Commun. 2024;15(1):9016. https://www.ncbi.nlm.nih.gov/pubmed/39532844

  6. Rosain J, Le Voyer T, Liu X, Gervais A, Polivka L, Cederholm A, et al. Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases. J Exp Med. 2024;221(11). https://www.ncbi.nlm.nih.gov/pubmed/39352576

  7. Olawoye IB, Waglechner N, McIntosh F, Akochy PM, Cloutier N, Grandjean Lapierre S, et al. Genomic Epidemiology of Mycobacterium abscessus on the Island of Montreal Not Suggestive of Healthcare-associated Person-to-Person Transmission. J Infect Dis. 2024. https://www.ncbi.nlm.nih.gov/pubmed/39189818

  8. Benoit P, Brazer N, de Lorenzi-Tognon M, Kelly E, Servellita V, Oseguera M, et al. Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections. Nat Med. 2024. https://www.ncbi.nlm.nih.gov/pubmed/39533109

  9. Arthur AW, El-Zein M, Burchell AN, Tellier PP, Coutlee F, Franco EL. Epidemiology of genital human papillomavirus infections in sequential male sex partners of young females. Clin Microbiol Infect. 2024;30(2):247-53. https://www.ncbi.nlm.nih.gov/pubmed/37981060

  10. Arthur AW, El-Zein M, Burchell AN, Tellier PP, Coutlee F, Franco EL. Detection and Clearance of Type-Specific and Phylogenetically Related Genital Human Papillomavirus Infections in Young Women in New Heterosexual Relationships. J Infect Dis. 2024;229(3):691-706. https://www.ncbi.nlm.nih.gov/pubmed/37824429

  11. De Marco C, Mondesert B, Desjardins M, Raymond-Paquin A. An Approach to Cardiac Implantable Electronic Device Pocket Infections: From Prevention to Diagnosis and Management. Card Electrophysiol Clin. 2024;16(4):383-91. https://www.ncbi.nlm.nih.gov/pubmed/39461829

  12. Benoit P, Wang S, Wang C, Chakravarti A, Villalba JA, Ali IKM, et al. Brainstorm: A case of granulomatous encephalitis. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2024;9(2):113-20. https://utppublishing.com/doi/10.3138/jammi-2023-0036

  13. Ametepe ESA, Andriamanoha N, Andrianomanana FR, Point F, Mangahasimbola RT, Dyachenko A, et al. Whole genome sequencing of M. tuberculosis for disease control in high-burden settings: study protocol for a cluster randomized controlled trial evaluating different community-wide intervention strategies in rural Madagascar. 2024;25(1):717. https://www.ncbi.nlm.nih.gov/pubmed/39456079

  14. Deceuninck G, Brousseau N, Lefebvre B, Quach C, Tapiero B, Bui YG, et al. Effectiveness of the ten- and thirteen-valent pneumococcal conjugate vaccines to prevent serotype 19A invasive pneumococcal disease in Quebec, Canada. A Canadian immunization research network (CIRN) study. Vaccine. 2024;42(26):126379. https://www.ncbi.nlm.nih.gov/pubmed/39332237

  15. Yero A, Goulet JP, Shi T, Costiniuk CT, Routy JP, Tremblay C, et al. Altered memory CCR6(+) Th17-polarised T-cell function and biology in people with HIV under successful antiretroviral therapy and HIV elite controllers. 2024;107:105274. https://www.ncbi.nlm.nih.gov/pubmed/39178742

  16. Huddart S, Yadav V, Sieberts SK, Omberg L, Raberahona M, Rakotoarivelo R, et al. A dataset of Solicited Cough Sound for Tuberculosis Triage Testing. Sci Data. 2024;11(1):1149. https://www.ncbi.nlm.nih.gov/pubmed/39424635

  17. RyPTIC Consortium. Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach. Nat Commun. 2024;15(1):488. https://www.ncbi.nlm.nih.gov/pubmed/38216576

  18. RyPTIC Consortium. Quantitative drug susceptibility testing for Mycobacterium tuberculosis using unassembled sequencing data and machine learning. PLoS Comput Biol. 2024;20(8):e1012260. https://www.ncbi.nlm.nih.gov/pubmed/39102420

  19. Brenner BG, Ibanescu RI, Oliveira M, Margaillan G, Lebouche B, Thomas R, et al. Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022. 2024;16(8). https://www.ncbi.nlm.nih.gov/pubmed/39205204

  20. Dzieciolowska S, Charest H, Roy T, Fafard J, Carazo S, Levade I, et al. Timing and Predictors of Loss of Infectivity Among Healthcare Workers With Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study. Clinical Infectious Diseases. 2023;78(3):613-24. https://doi.org/10.1093/cid/ciad535

  21. Dagher O, Passos-Castilho AM, Sareen V, Labbe AC, Barkati S, Luong ML, et al. Impact of Language Barriers on Outcomes and Experience of COVID-19 Patients Hospitalized in Quebec, Canada, During the First Wave of the Pandemic. J Immigr Minor Health. 2024;26(1):3-14. https://www.ncbi.nlm.nih.gov/pubmed/37902902

  22. Haslund-Gourley BS, Woloszczuk K, Hou J, Connors J, Cusimano G, Bell M, et al. IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition. Nature Communications. 2024;15(1):404. https://doi.org/10.1038/s41467-023-44211-0

  23. Baldassarre L, Quach-Thanh C, Mouajou Feujio V, Tadount F, Deyirmendjian C, Lefebvre MA, et al. Incidence and risk factors for recurrent Clostridioides difficile infection in pediatric at-risk groups in selected Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) hospitals. Infect Control Hosp Epidemiol. 2024;45(2):182-7. https://www.ncbi.nlm.nih.gov/pubmed/37700539

  24. Weitzel T, Brown A, Libman M, Perret C, Huits R, Chen L, et al. Intestinal protozoa in returning travellers: a GeoSentinel analysis from 2007 to 2019. J Travel Med. 2024;31(4). https://www.ncbi.nlm.nih.gov/pubmed/38245913

  25. Zimmer AJ, Tsang LY, Jolicoeur G, Tannir B, Batisse E, Pando C, et al. Incidence of cough from acute exposure to fine particulate matter (PM2.5) in Madagascar: A pilot study. PLOS Glob Public Health. 2024;4(7):e0003530. https://www.ncbi.nlm.nih.gov/pubmed/39058715

  26. Saeed S, Thomas T, Dinh DA, Moodie E, Cox J, Cooper C, et al. Frequent Disengagement and Subsequent Mortality Among People With HIV and Hepatitis C in Canada: A Prospective Cohort Study. Open Forum Infect Dis. 2024;11(5):ofae239. https://www.ncbi.nlm.nih.gov/pubmed/38798898

  27. Peled Y, Ducharme A, Kittleson M, Bansal N, Stehlik J, Amdani S, et al. International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates-2024. J Heart Lung Transplant. 2024. https://www.ncbi.nlm.nih.gov/pubmed/39115488

  28. Ng K, Morais S, Wissing MD, Burchell AN, Tellier PP, Coutlee F, et al. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women. Microbiol Spectr. 2024;12(6):e0022924. https://www.ncbi.nlm.nih.gov/pubmed/38687066

  29. Mboumba Bouassa RS, Giorgini G, Silvestri C, Muller C, Nallabelli N, Alexandrova Y, et al. Plasma endocannabinoidome and fecal microbiota interplay in people with HIV and subclinical coronary artery disease: Results from the Canadian HIV and Aging Cohort Study. iScience. 2024;27(8):110456. https://www.ncbi.nlm.nih.gov/pubmed/39156649

  30. Marty C, Adam JP, Martel-Laferriere V, Doucet S, Martel D. Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients. Support Care Cancer. 2024;32(8):541. https://www.ncbi.nlm.nih.gov/pubmed/39046551

  31. Marois L, Le Gal C, Cros G, Falcone EL, Chapdelaine H. Refractory wound healing and cytopenias treated with a sodium-glucose cotransporter-2 inhibitor in a patient with glucose-6-phosphatase catalytic subunit 3 deficiency. JAAD Case Rep. 2024;49:22-4. https://www.ncbi.nlm.nih.gov/pubmed/38883182

  32. Makarenko I, Minoyan N, Bordier Hoj S, Udhesister S, Martel-Laferriere V, Jutras-Aswad D, et al. Determinants of psychological distress during the COVID-19 pandemic among people who use drugs in Montreal, Canada. Drug Alcohol Rev. 2024. https://www.ncbi.nlm.nih.gov/pubmed/38741361

  33. Kimura M, Rinaldi M, Kothari S, Giannella M, Anjan S, Natori Y, et al. Invasive aspergillosis in liver transplant recipients in the current era. Am J Transplant. 2024. https://www.ncbi.nlm.nih.gov/pubmed/38801991

  34. Huletsky A, Loo VG, Longtin Y, Longtin J, Trottier S, Tremblay CL, et al. Comparison of rectal swabs and fecal samples for the detection of Clostridioides difficile infections with a new in-house PCR assay. Microbiol Spectr. 2024;12(6):e0022524. https://www.ncbi.nlm.nih.gov/pubmed/38687067

  35. Colas S, Marie B, Morin S, Milhe-Poutingon M, Foucault P, Chalvin S, et al. New sensitive tools to characterize meta-metabolome response to short- and long-term cobalt exposure in dynamic river biofilm communities. Sci Total Environ. 2024;927:171851. https://www.ncbi.nlm.nih.gov/pubmed/38518822

  36. Colas S, Marie B, Milhe-Poutingon M, Lot MC, Boullemant A, Fortin C, Le Faucheur S. Meta-metabolomic responses of river biofilms to cobalt exposure and use of dose-response model trends as an indicator of effects. J Hazard Mater. 2024;470:134099. https://www.ncbi.nlm.nih.gov/pubmed/38547754

  37. Chawla S, Kaida A, Brouillette MJ, Kleiner B, Dubuc D, Skerritt L, et al. Mental health service use and shortages among a cohort of women living with HIV in Canada. BMC Health Serv Res. 2024;24(1):923. https://www.ncbi.nlm.nih.gov/pubmed/39135046

  38. Bu S, Royston L, Mabanga T, Berini CA, Tremblay C, Lebouche B, et al. Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity. Front Immunol. 2024;15:1377126. https://www.ncbi.nlm.nih.gov/pubmed/38686386

  39. Boutin CA, Durocher F, Beauchemin S, Ziegler D, Abou Chakra CN, Dufresne SF. Breakthrough Invasive Fungal Infections in Patients With High-Risk Hematological Disorders Receiving Voriconazole and Posaconazole Prophylaxis: A Systematic Review. Clin Infect Dis. 2024;79(1):151-60. https://www.ncbi.nlm.nih.gov/pubmed/38752732

  40. Boncheva I, Poudrier J, Falcone EL. Role of the intestinal microbiota in host defense against respiratory viral infections. Curr Opin Virol. 2024;66:101410. https://www.ncbi.nlm.nih.gov/pubmed/38718575

  41. Alessandrini J, Cox J, de Pokomandy A, Hart TA, Grace D, Grennan T, et al. Prevalence of Oral Human Papillomavirus Infection Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men in Canada, 2017-2019. J Infect Dis. 2024. https://www.ncbi.nlm.nih.gov/pubmed/39041706

  42. Ozonoff A, Jayavelu ND, Liu S, Melamed E, Milliren CE, Qi J, et al. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study. Nat Commun. 2024;15(1):216. https://www.ncbi.nlm.nih.gov/pubmed/38172101

  43. Sacks-Davis R, van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, et al. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. Lancet HIV. 2024;11(2):e106-e16. https://www.ncbi.nlm.nih.gov/pubmed/38224708

  44. Wiche Salinas TR, Zhang Y, Gosselin A, Rosario NF, El-Far M, Filali-Mouhim A, et al. Alterations in Th17 Cells and Non-Classical Monocytes as a Signature of Subclinical Coronary Artery Atherosclerosis during ART-Treated HIV-1 Infection. 2024;13(2). https://www.ncbi.nlm.nih.gov/pubmed/38247848

  45. Wiche Salinas TR, Zhang Y, Gosselin A, Do Rosario NF, El-Far M, Filali-Mouhim A, et al. A Blood Immunological Signature of Subclinical Coronary Artery Atherosclerosis in People Living with HIV-1 Receiving Antiretroviral Therapy. bioRxiv. https://www.ncbi.nlm.nih.gov/pubmed/38187644

  46. Ramani H, Gosselin A, Bunet R, Jenabian MA, Sylla M, Pagliuzza A, et al. IL-32 Drives the Differentiation of Cardiotropic CD4+ T-Cells Carrying HIV DNA in People Living with HIV. J Infect Dis. 2023. https://www.ncbi.nlm.nih.gov/pubmed/38113908

  47. Prosty C, Katergi K, Nguyen A, Luo OD, Sorin M, Cherniak V, et al. Risk of infectious adverse events of venetoclax therapy for hematologic malignancies: a systematic review and meta-analysis of RCTs. Blood Adv. 2024;8(4):857-66. https://www.ncbi.nlm.nih.gov/pubmed/38154071

  48. Nantel E, Mayrand MH, Audibert F, Niyibizi J, Brassard P, Laporte L, et al. Association between the Mode of Delivery and Vertical Transmission of Human Papillomavirus. Viruses. 2024;16(2). https://www.ncbi.nlm.nih.gov/pubmed/38400078

  49. Morais S, Wissing MD, Khosrow-Khavar F, Burchell AN, Tellier PP, Coutlee F, et al. Serologic response to human papillomavirus genotypes following vaccination: findings from the HITCH cohort study. Infect Dis (Lond). 2024;56(1):66-72. https://www.ncbi.nlm.nih.gov/pubmed/37994805

  50. Luong ML, Nakamachi Y, Silveira FP, Morrissey CO, Danziger-Isakov L, Verschuuren EAM, et al. Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel. Transpl Infect Dis. 2024:e14251. https://www.ncbi.nlm.nih.gov/pubmed/38351512

  51. Lee CH, Banoei MM, Ansari M, Cheng MP, Lamontagne F, Griesdale D, et al. Using a targeted metabolomics approach to explore differences in ARDS associated with COVID-19 compared to ARDS caused by H1N1 influenza and bacterial pneumonia. Crit Care. 2024;28(1):63. https://www.ncbi.nlm.nih.gov/pubmed/38414082

  52. Le AS, Labbe AC, Fourmigue A, Dvorakova M, Cox J, Fortin C, et al. Mycoplasma genitalium infection among gay, bisexual and other men who have sex with men in Montreal, Canada. Can Commun Dis Rep. 2023;49(11-12):477-86. https://www.ncbi.nlm.nih.gov/pubmed/38504874

  53. Laurie C, El-Zein M, Tota JE, Tellier PP, Coutlee F, Burchell AN, Franco EL. Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) trial. J Med Virol. 2024;96(4):e29604. https://www.ncbi.nlm.nih.gov/pubmed/38606779

  54. Khayargoli P, Mayrand MH, Niyibizi J, Audibert F, Laporte L, Lacaille J, et al. Association between Human Papillomavirus 16 Viral Load in Pregnancy and Preterm Birth. 2024;16(2). https://www.ncbi.nlm.nih.gov/pubmed/38400073

  55. Kassam P, El-Zein M, Laurie C, Tota JE, Tellier PP, Coutlee F, et al. Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads in gay, bisexual, and other men who have sex with men. J Med Virol. 2024;96(3):e29562. https://www.ncbi.nlm.nih.gov/pubmed/38528834

  56. Grunebaum E, Arnold DE, Logan B, Parikh S, Marsh RA, Griffith LM, et al. Allogeneic hematopoietic cell transplantation is effective for p47phox chronic granulomatous disease: A Primary Immune Deficiency Treatment Consortium study. J Allergy Clin Immunol. 2024. https://www.ncbi.nlm.nih.gov/pubmed/38290608

  57. Fournelle D, Mostefai F, Brunet-Ratnasingham E, Poujol R, Grenier JC, Galvez JH, et al. Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis. 2024;16(3). https://www.ncbi.nlm.nih.gov/pubmed/38543708

  58. Doyon-Laliberte K, Aranguren M, Chagnon-Choquet J, Batraville LA, Dagher O, Richard J, et al. Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations. Curr Issues Mol Biol. 2023;46(1):25-43. https://www.ncbi.nlm.nih.gov/pubmed/38275663

  59. Doyle CM, Milwid RM, Cox J, Xia Y, Lambert G, Tremblay C, et al. Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montreal (Canada): a modelling study of surveillance and survey data. J Int AIDS Soc. 2023;26(12):e26194. https://www.ncbi.nlm.nih.gov/pubmed/38054579

  60. Donko A, Sharapova SO, Kabat J, Ganesan S, Hauck FH, Bergerson JRE, et al. Clinical and functional spectrum of RAC2-related immunodeficiency. Blood. 2024;143(15):1476-87. https://www.ncbi.nlm.nih.gov/pubmed/38194689

  61. De Wals P, Desjardins M. Minimal interval for the administration of a pneumococcal polysaccharide vaccine following the administration of a pneumococcal conjugate vaccine. Vaccine. 2024;42(12):2933-6. https://www.ncbi.nlm.nih.gov/pubmed/38346915

  62. De Wals P, Desjardins M. Influenza vaccines may protect against cardiovascular diseases: The evidence is mounting and should be known by the Canadian public health community. Can Commun Dis Rep. 2023;49(10):433-8. https://www.ncbi.nlm.nih.gov/pubmed/38481651

  63. Cloutier Charette W, Rabodoarivelo MS, Point F, Knoblauch AM, Andrianomanana FR, Hall MB, et al. Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing. Diagn Microbiol Infect Dis. 2024;109(2):116249. https://www.ncbi.nlm.nih.gov/pubmed/38537504

  64. Boutin CA, Luong ML. Update on therapeutic approaches for invasive fungal infections in adults. Ther Adv Infect Dis. 2024;11:20499361231224980. https://www.ncbi.nlm.nih.gov/pubmed/38249542

  65. Benlarbi M, Richard J, Bourassa C, Tolbert WD, Chartrand-Lefebvre C, Gendron-Lepage G, et al. Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia. J Infect Dis. 2024;229(3):763-74. https://www.ncbi.nlm.nih.gov/pubmed/38035854

  66. Al-Soneidar WA, Harper S, Coutlee F, Gheit T, Tommasino M, Nicolau B. Prevalence of Alpha, Beta, and Gamma Human Papillomaviruses in Patients With Head and Neck Cancer and Noncancer Controls and Relation to Behavioral Factors. J Infect Dis. 2024;229(4):1088-96. https://www.ncbi.nlm.nih.gov/pubmed/37584283

  67. Pando C, Hazel A, Tsang LY, Razafindrina K, Andriamiadanarivo A, Rabetombosoa RM, et al. A social network analysis model approach to understand tuberculosis transmission in remote rural Madagascar. BMC Public Health. 2023;23(1):1511. https://www.ncbi.nlm.nih.gov/pubmed/37558982

 

 

Pour obtenir les documents
L’accès au texte intégral des documents est restreint au personnel et aux médecins du CHUM en fonction des abonnements de la bibliothèque. Certains documents sont en accès libre sur le web.

Si vous êtes branchés sur le réseau CHUM :
Cliquer sur les liens fournis pour chaque référence pour vérifier la disponibilité du texte intégral.
Pour les articles provenant de PubMed, cliquer préalablement sur le lien suivant pour afficher la disponibilité du document.

Si vous êtes dans un autre établissement et que vous n’arrivez pas à accéder au texte intégral d’un article à partir du lien donné, vérifier auprès de la bibliothèque de votre institution en donnant la référence complète du document.


Avis de non-responsabilité

    • 1. EXCLUSION DE GARANTIES ET LIMITATION DE RESPONSABILITÉ

 

Le contenu des veilles informationnelles ou stratégiques (ci-après appelée « Veilles ») est mis à votre disposition à titre informatif pour un usage personnel exclusif. Tout usage commercial du contenu des Veilles est strictement interdit.

Tous les éléments, articles, rapports ou toute autre source d’information figurant dans les Veilles, vous sont fournis « tels quels », sans garantie d’aucune sorte. Eu égard aux propos tenus dans les articles et les rapports sélectionnés pour les Veilles, le CHUM n’offre aucune garantie notamment d’exhaustivité, de fiabilité, d’actualité et d’exactitude.Le CHUM ne pourra en aucun cas être tenu responsable envers quiconque de tout dommage quel qu’il soit, même ceux directs, encouru notamment des suites de toute réclamation, action ou poursuite découlant, même directement, de l’utilisation de ces Veilles.

    • 2. RESPONSABILITÉ RELATIVES AUX LIENS

 

Les Veilles contiennent des liens vers des sites Web créés et mis à jour par des tierces parties. Ces liens sont fournis pour la commodité des utilisateurs seulement. Le CHUM n’endosse et ne garantit, ni explicitement ni implicitement, l’exactitude ou l’intégralité ni du contenu de ces hyperliens ni des opinions qui y sont exprimées.

Le CHUM n’assume aucune responsabilité à l’égard de ces sites Web externes.

    • 3. PROPRIÉTÉ INTELLECTUELLE

 

Le CHUM prend tous les moyens raisonnables afin de respecter les droits de propriété intellectuelle afférents au contenu des Veilles et aux modalités du prêt entre bibliothèques, émises par l’Université de Montréal. Le contenu des Veilles, incluant la manière dont il est présenté, sont notamment protégés par la Loi sur le droit d’auteur (L.R.C. (1985), ch. C-42).

Le CHUM ne donne aucune garantie et ne fait aucune déclaration à l’effet que le contenu de ces veilles n’enfreint aucun droit d’une autre personne ou entité.

Le téléchargement, la reproduction en un seul exemplaire ou le tirage sur papier des Veilles ne sont autorisés qu’à des fins de sauvegarde et pour un usage privé et non commercial. Tout téléchargement, reproduction, édition, diffusion sur Internet, utilisation à des fins commerciales ou publiques, distribution, publication sur un autre site ou sur quelque autre forme ainsi que toute autre utilisation est strictement interdite, à moins d’être faite dans le respect des règles de propriété intellectuelle applicables.